Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.！ 京ICP备19006400号-1 Powered by 300.cn
美科
Links：
The M&A Fund initiated by Jiuzhitang achieved new progress in its investment efforts in the stem cells field – Stemedica Cell Technologies, Inc. of which the Fund has holding interests announced positive data from its clinical study on cerebral stroke.
Source:
Release time：
2019/01/12 13:39
Page view
On January 12, 2019, the M&A Fund initiated by Jiuzhitang achieved new progress in its investment efforts in the stem cells field – Stemedica Cell Technologies, Inc. a compnay which received investment from Yonghe Qihang Fund initiated by Jiuzhitang announced positive data from its clinical study on cerebral stroke.